Every Veterinary Clinic Stocking Ketamine Is Running a Pharmacy the DEA Won't Let Them Forget
Every veterinary practice that keeps ketamine, buprenorphine, or pentobarbital in a locked cabinet is also, whether the owner ever framed it that way, a DEA-registered handler of Schedule II through V controlled substances - carrying close to the same inventory and recordkeeping obligations as a retail pharmacy, just enforced against animal hospitals instead of a corner drugstore.
The DEA doesn’t grade on a curve for a four-legged patient
A veterinarian who administers or dispenses a controlled substance needs their own DEA registration, separate from the practice’s, and has to run a biennial physical inventory of every Schedule II-V drug on hand, log each administration with patient, date, dosage, and prescriber, and reconcile what was ordered against what was used or wasted down to the milliliter. The DEA doesn’t treat a missing count as a clerical issue. A discrepancy found during an inspection - even one caused by sloppy logging rather than actual diversion - can trigger a registration suspension that stops a practice from stocking the sedatives and pain control it needs to operate at all.
Where the count actually breaks
The failure point is rarely the full, sealed vials sitting in the safe. It’s the partial doses: a 10mL ketamine vial split across four surgeries over two weeks, the small amount drawn up and then wasted because a procedure got cancelled, the euthanasia solution where “waste” is the entire point of the drug’s use. Each of those needs its own documented, witnessed reconciliation logged at the time - not reconstructed from memory during a DEA audit six months later. Multi-doctor and multi-location practices compound the problem, since the same ketamine supply gets split across associates, relief vets, and technicians, and the DEA holds the individual registrant responsible for every milliliter regardless of who actually drew it up.
Why the practice management system never catches it
Mainstream veterinary practice management platforms were built around appointments, boarding, and client billing, not controlled substance chain of custody. Inventory modules track reorder points, not witnessed waste logs tied to a specific registrant’s DEA number. That gap looks harmless until a practice faces an actual DEA inspection or a state veterinary board complaint, at which point “we track it in a paper binder by the safe” doesn’t hold up - a records problem closer to the compounding pharmacy beyond-use-date argument, where the paperwork behind a drug matters as much as the drug itself, than to anything in mainstream practice management.
What actually gets a practice to replace it
It’s almost never a routine renewal. It’s a new associate bringing their own DEA registration into a practice with no clean onboarding process for it, a relief vet rotation that leaves gaps in who logged what, or - most often - a state board inspection or DEA audit letter that exposes how much of the controlled substance log has been running on trust instead of documentation. That’s the moment a practice manager starts looking for software that ties every draw, waste event, and reconciliation to a specific registrant instead of a generic inventory count.
Vendors building tools for the broader healthcare and life sciences market, including those selling clinical documentation software into veterinary practices, are increasingly running into this exact gap: documentation speed doesn’t impress a DEA inspector if the controlled substance log behind it won’t reconcile.
Talk to us if your outbound into veterinary practices still pitches scheduling or documentation speed instead of the controlled substance recordkeeping gap that actually triggers DEA registration risk.